The Patent Finder

Terms ending in 2042

Astellas US LLC

Every in-force patent on Astellas US LLC's record whose computed term ends in 2042, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 11,957,696Abiraterone Prodrugs
In force
 · Medium confidence
Astellas US LLCIn forceMedium confidence
US 12,296,026Transcription Regulatory Elements and Uses Thereof
In force
 · High confidence
Astellas Gene Therapies, Inc.In forceHigh confidence
US 12,514,858CD38 Inhibitors
In force
 · High confidence
Astellas Engineered Small Molecules US, IncorporatedIn forceHigh confidence
3 of 3 patents shown. Soonest term end first, then patent number.
Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited